These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8592591)

  • 21. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
    Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
    Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on the plasma clearance of an albumin-bound furan dicarboxylic acid.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1995; 10(5):648-52. PubMed ID: 7566577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of vitamin A and retinol binding protein in chronic renal patients treated by continuous ambulatorial peritoneal dialysis.
    Vannucchi MT; Vannucchi H; Humphreys M
    Int J Vitam Nutr Res; 1992; 62(2):107-12. PubMed ID: 1517032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
    Borazan A; Aydemir S; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood serum hepatocyte growth factor in children with chronic renal failure treated with CAPD and HD].
    Szprynger K; Szczepańska M; Morawiec-Knysak A; Dyduch A
    Pol Merkur Lekarski; 2000 Apr; 8(46):270-1. PubMed ID: 10897645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Barr J; Baillod RA
    Arzneimittelforschung; 1994 Apr; 44(4):522-6. PubMed ID: 8011008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silicon accumulation in dialysis patients.
    Gitelman HJ; Alderman FR; Perry SJ
    Am J Kidney Dis; 1992 Feb; 19(2):140-3. PubMed ID: 1739095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary and serum silicon in normal and uraemic individuals.
    Dobbie JW; Smith MB
    Ciba Found Symp; 1986; 121():194-213. PubMed ID: 3743230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High fluoride exposure in hemodialysis patients.
    Bello VA; Gitelman HJ
    Am J Kidney Dis; 1990 Apr; 15(4):320-4. PubMed ID: 2321644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silicon-related syndrome in dialysis patients.
    Saldanha LF; Gonick HC; Rodriguez HJ; Marmelzat JA; Repique EV; Marcus CL
    Nephron; 1997; 77(1):48-56. PubMed ID: 9380238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of water quality and haemodialysis fluid composition.
    Hoenich NA; Ronco C; Levin R
    Blood Purif; 2006; 24(1):11-8. PubMed ID: 16361834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trace elements and complications in patients undergoing chronic hemodialysis.
    Hosokawa S; Oyamaguchi A; Yoshida O
    Nephron; 1990; 55(4):375-9. PubMed ID: 2392189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aluminium and silicon speciation in human serum by lon-exchange high-performance liquid chromatography-electrothermal atomic absorption spectrometry and gel electrophoresis.
    Wróbel K; González EB; Wróbel K; Sanz-Medel A
    Analyst; 1995 Mar; 120(3):809-15. PubMed ID: 7741232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased serum strontium levels in dialysis patients: an epidemiological survey.
    Schrooten I; Elseviers MM; Lamberts LV; De Broe ME; D'Haese PC
    Kidney Int; 1999 Nov; 56(5):1886-92. PubMed ID: 10571798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral silicon supplementation: an effective therapy for preventing oral aluminum absorption and retention in mammals.
    Domingo JL; Gómez M; Colomina MT
    Nutr Rev; 2011 Jan; 69(1):41-51. PubMed ID: 21198634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.